Skip to main content
Watch Insiders
AGIOHealthcare

Agios Pharmaceuticals Inc (AGIO) Insider Trading

In the last 90 days, 1 Agios Pharmaceuticals Inc (AGIO) insider reported no open-market purchases and 2 sales totaling $989,042. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 22, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 22, 2026Sarah GheuensChief Medical OfficerSale1,989$37.53$74,642
Aug 4, 2026Sarah GheuensChief Medical OfficerSale30,000$30.48$914,400
Jul 1, 2026Sarah GheuensChief Medical OfficerSale4,007$37.56$150,503

Common questions

AGIO insider trading FAQ

Are AGIO insiders buying or selling?
Over the last 90 days, AGIO insiders were net sellers, reporting $0.00 of open-market purchases and $989,042 of sales.
When was the last AGIO insider purchase?
No open-market insider purchase of Agios Pharmaceuticals Inc stock was reported in the last 90 days.
Where does AGIO insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Agios Pharmaceuticals Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.